SUMMARY Plasma renin activity, arterial and venous angiotensin II (A II) concentrations, and plasma aldosterone concentration were measured in 16 normal subjects (mean age = 34 years) after 8 hours of recumbency, following 2 hours of ambulation, and again 30 minutes after administration of furosemide intravenously. Measurements were obtained during periods of sodium restriction and again during sodium surfeit. Both arterial and venous A II exhibited a 3-fold increase from low values of 8.8 ± 2.5 and 8.6 ± 2.5 pg/ml of plasma, respectively, during recumbency on high sodium intake to values of 23.9 ± 4 . 1 and 26.5 ± 6.2 pg/ml, respectively, following intravenous furosemide during sodium restriction. Corresponding values for aldosterone exhibited a 5-fold rise from 5.6 ng/100 ml to 32.0 ng/100 ml, whereas plasma renin activity (PRA) measured by an in vitro assay exhibited a 20-fold rise from 0.6 ± 0.2 ng of angiotensin I (AI) generated per ml per hour to 13.1 ng/ml per hour. Despite the disparity in the magnitude of these increases, significant correlations were identified between all four of the measured parameters, indicating a major role of the renin-angiotensin system in regulating aldosterone output in response to volume and posturerelated stimuli. Values of arterial and venous immunoreactive A 11 were closely correlated (r = +0.72, P <0.005), but significant differences were demonstrated between low and high salt periods, suggesting that changes in metabolism of A II in the peripheral circulation may occur during sodium restriction.
THE DEMONSTRATION of an increase in aldosterone secretion and excretion in response to infusion of angiotensin II (A II)J by Laragh et al. 1 and Genest et al. 2 identified the role of the renin-angiotensin system in aldosterone output. Subsequent studies characterized the response of this system to sodium intake, posture, blood volume and extracellular fluid volume, and related stimuli. 3 ' 8 From these data it was inferred that a change in plasma renin activity (PRA) was associated with a concordant change in plasma concentration of A II, thereby controlling the rate of aldosterone production. 7 Attempts to confirm the existence of this sequence directly by measurement of plasma A II under similar conditions have produced conflicting information. Nielsen and Moiler" used bioassay techniques but failed to detect changes in A II in response to salt depletion alone, although the addition of diuretics produced increased levels of angiotensin II in five of seven normal subjects. Radioimmunoassay has increased the sensitivity of measurement of A II but use of this method has not consistently produced data in accord with earlier studies in which only renin or renin plus aldosterone were measured. Page et al., 9 Gocke et al.J 0 and Brown et a l . " noted significant increases in A II in response to severe sodium restriction in normal subjects. Brown et al. also identified a significant correlation between levels of A II and plasma aldosterone. Catt and associates' 2 failed to find significant changes in plasma A II levels in response to posture or sodium restriction but demonstrated an increase following chlorothiazide administration. Mendelsohn et a l . " also failed to note an increase in A II with sodium deprivation, although plasma aldosterone values rose. On the basis of similar data, Best and associates 14 concluded that the dissociation implied an alternate mechanism of control of aldosterone.
We have used an assay developed in our laboratory 15 to compare responses in arterial and venous A II, renin, and aldosterone in normal subjects exposed to variations in salt intake and to administration of diuretics. Significant correlations were demonstrated between these four variables as they changed in response to the imposed stimuli.
Methods
Sixteen normal volunteers (average age, 34 years; range, 24-47) were admitted to the clinical research ward of the Johns Hopkins Hospital after the purpose of the study had been explained and their consent obtained. Each was maintained on a regular diet permitting salt ad libitum plus the additional administration of 2 g of sodium chloride in tomato juice three times daily (salt supplement to diet = 102 VOL. 38, No. 6, JUNE 1976 mEq of Na + ). This was maintained for 5 days and at the end of this period samples were obtained for renin, A II, and aldosterone as outlined below. The subjects were then given the standard 1-g salt diet from the hospital dietary department for an additional 5 days. At the end of the 5-day period of sodium restriction, blood samples were again obtained. Daily urinary sodium and creatinine were determined to monitor sodium excretion. Blood pressure and body weight were monitored during both periods.
COLLECTION OF BLOOD SAMPLES
All blood samples (venous and arterial) were obtained at approximately 8 a.m. after a minimum of 8 hours of recumbency and before the subject had risen from the supine position after the night's sleep. After 2 hours of ambulation, arterial and venous blood were again obtained and then a dose of 20 mg of furosemide (Lasix) was given intravenously. Thirty minutes after furosemide had been administered, arterial and venous blood samples were drawn for a third time. The procedure was identical during high and low sodium intake periods and provided six samples from each subject.
Blood samples were drawn into chilled plastic syringes and immediately transferred to chilled centrifuge tubes, centrifuged at 2,000 rpm at 4°C, separated, frozen, and stored at -20°C until assayed. 15 ' 6 All blood samples for measurement of renin and A II were drawn into ethylenediaminetetraacetic acid (EDTA) but samples for aldosterone were drawn in plastic syringes containing 1,000 U of purified beef lung heparin: otherwise all blood samples were handled in an identical fashion.
MEASUREMENT OF PLASMA RENIN ACTIVITY PRA was measured by the radioimmunoassay technique described by Haber and associates' 6 Antibody to angiotensin I (A I) was raised in rabbits after immunization with A I conjugated to albumin and administered with Freund's adjuvant.
17 125 I-labeled A I was prepared by the method of Nielsen et al. 18 and used in the assay. Under the standard conditions outlined by Haber et al. 18 the assay was capable of detecting renin activity at a level of 0.1 ng/ml of plasma per hour. Intra-assay variability (C.V.) was 9.5% and interassay variability 15%.
MEASUREMENT OF A II
A II was measured on an ultrafiltrate of plasma by a radioimmunoassay procedure developed in this laboratory and recently described. 15 The coefficient of variation for samples measured in duplicate (within assay) is 14%. All measurements on a single subject were made within a single assay. The antibody used for the assay exhibits 50% cross-reactivity with the 3-8 hexapeptide of A II and 1% cross-reactivity with A I. Levels of A I in plasma measured as the blank for determination of renin activity were never high enough to provide significant interference with A II measurements. No means of independent measurement of the .3-8 hexapeptide was available. This influences the measurements on arterial blood samples relatively little but probably is a significant fraction of the immunoreactive material in the venous blood. 12 For this reason A II measurements are most accurately considered immunoreactive A l l .
PLASMA AND URINE ELECTROLYTE AND CREATININE DETERMINATIONS
Plasma electrolytes were measured in the clinical chemistry laboratory. Urinary sodium levels at the time of sampling for renin, A II, and aldosterone were determined by measurement of electrolytes in a 24-hour urine collection ending at 8 a.m. on the day of samplings. Electrolytes and creatinine in the urine were measured by procedures previously reported. 4 
Results
Values for urinary sodium in the 24-hour urine samples revealed that the mean sodium excretion during the high salt period was 298 ± 24.6 (SEM) mEq for the entire group and had fallen to 22.7 ± 3.2 mEq at the time of sampling during sodium restriction. The average urine volume collected at the end of 30 minutes after furosemide administration was 550 ml (urine flow, 18 ml/min) during high salt intake and 367 ml (urine flow, 12 ml/min) during sodium restriction; these values indicate an excellent response to the diuretic for both periods. The mean weight loss for the entire group of subjects between the periods of high and low sodium intake was 2.64 ± 0.34 kg (SEM).
The data for PRA, venous immunoreactive A II, arterial immunoreactive A l l , and venous aldosterone for both the low and high salt periods are presented in Table 1 . The data for the low salt period represent moderately severe salt restriction but reflect an intake significantly higher than the 10 mEq of sodium employed in some previous studies in which A II was measured for normal subjects. 8 PRA increased significantly when subjects changed from the supine to the erect position during periods of high and low salt intake (Table 1) (P = 0.005 or less), and exhibited a further significant increase after injection of furosemide during the period of high salt intake. In contrast, the furosemide-induced increase during sodium restriction was not significant. The change in PRA with change in posture was greater after salt depletion than after salt loading. PRA correlated inversely with the total sodium excretion when measured for the recumbent patient (r = -0.471, P < 0.05) and after 2 hours of ambulation (r = -0.529, P < 0.02). The magnitude of change in PRA between the supine and erect positions also varied inversely with the total 24-hour sodium excretion (r = -0.560; P < 0.01), and when this was g300 mEq/24 hours there was virtually no change in PRA with the change in position (Fig. 1) .
RELATION BETWEEN PRA, A II, AND ALDOSTERONE
Analysis of Ungrouped Data. Each of the 96 blood samplings for the 16 subjects was designed to provide data on simultaneous values of PRA, arterial and venous A II, and plasma aldosterone concentration. The data were first examined for correlations between these parameters in the total pool of samples. Thus for 90 of 96 venous blood samples measurements were completed for both PRA and A II; the correlation between these two variables was significant (r = +0.42; n = 90; P < 0.005). Although fewer arterial samples were available, a significant correlation likewise was demonstrated between arterial A 11 and renin (r = +0.33; n = 75; P < 0.005). The values are included in Table 2 . In similar fashion, comparison of arterial and venous values for A II for all samples yielded a highly significant correlation (r = +0.72; n = 76, P < 0.005). The relation between venous and arterial A II, defined from these data, ( simultaneously obtained arterial value for the entire data set, a finding in keeping with the observations reported by Catt et al. 12 It does appear from the present study, however, that there are differences that depend on the level of salt intake (see below).
Arterial A II and PRA also correlated significantly with plasma aldosterone concentration. For the ungrouped data, arterial A II vs. aldosterone yielded an r = +0.28; n = 81; P < 0.02. For PRA vs. aldosterone the corresponding values were r = +0.28; n = 91; P < 0.02. Thus for the total group of observations, significant correlations were identified between PRA, arterial and venous A II, and plasma aldosterone. Further examination of the data included evaluation of the influence of sodium intake, posture, and intravenous administration of diuretics on renin-angiotensin aldosterone system.
Responses of PRA, A II, and Aldosierone to Sodium Intake Posture and Diuretics. The influence of sodium intake, posture and administration of diuretics was evaluated from the data as grouped in Table I . Correlations between each of the four variables (PRA, arterial A II, venous A II, and aldosterone) were tested using the mean values of the six sets of data obtained from the subjects in the supine and upright positions and following intravenous furosemide on both low and high sodium intake. Results are shown in Figures 3 and 4 and values for all the correlation coefficients are presented in Table 2 . All correlation coefficients are highly significant (P < 0.005 for 4 degrees of freedom), indicating concordant responses in PRA, arterial and venous A II, and plasma aldosterone in response to the physiological stimuli of postural change and alterations in sodium intake as well as to administration of diuretic.
RELATION BETWEEN ARTERIAL AND VENOUS A II
In addition to the high correlations between arterial and venous A II described above, comparison of arterial and venous A II from the high and low salt periods revealed a difference in behavior that was significant. Separate calculation of the relation between venous and arterial A II for the high and low salt periods yielded the following regression equations:"-2° The intercepts of these two equations are nearly identical and probably not different from zero. There does appear to be a significant disparity between the two slopes (regression coefficients). A test of this disparity (null hypothesis; t = difference between slopes/SE of difference = 0.29/0.118 = 2.45: P < 0.025; n = 70) establishes the difference as significant., 20 Thus during the high salt period the relative arteriovenous extraction, or conversion to metabolites that were not immunologically reactive, appeared to be significantly greater than that observed during the low salt period.
Inspection of the data from which these equations are calculated ( fig. 5A and B) , however, reveals this difference is not a uniform one that characterizes all individuals subjected to sodium restriction. Instead, the different slope for the low sodium group appears to result from nine observations in which venous A II concentration exceeded the corresponding arterial value by a substantial amount. In the remainder, the relation between arterial and venous A II Table 2. differs only moderately, if at all, from that seen in the high salt group. It thus appears that the major part of the difference may be attributed to production of A II in the peripheral capillary beds in some individuals on restricted sodium intake.
Discussion
The present study reveals a highly significant positive correlation between PRA, arterial and venous A II, and aldosterone when the mean value for each of these parameters is compared for the six sets of conditions defined by variations in posture, sodium intake, and responses to diuretics (Tables 1 and 2 ). When similar comparisons were made for the individual observations from each subject in 
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FIGURE 4
Relationship between simultaneously measured arterial and venous values of immunoreactive A II, in pg (p.ug)/ml. A highly significant correlation exists (r = + 0.72: P < 0.005) between these two measurements although it is apparent that substantial disparities were occasionally encountered (see Fig. 5A and B) .
the study, significant correlations still were demonstrable, although then the degree of correlation was much lower than the corresponding correlations between the mean values for the parameters being compared (Table 1) . This difference is probably a reflection of the extent to which other factors, presently unidentified, tend to modulate the response of the renin-angiotensin-aldosterone system to stimuli related to posture, salt intake, and administration of diuretics. Factors such as the influence of the autonomic nervous system on renin release from the kidney, 21 -22 the role of adrenocorticotropic hormone (ACTH) in the regulation of aldosterone production and release, 23 and the state of potassium balance all exert significant influences upon this important control system. Thus it is possible that any or all of these factors could have modified the response obtained in an individual subject in the present study and thereby tended to reduce the degree of correlation between individual responses in each subject. The present observations confirm and extend the studies of Page et al. 9 and Brown et al.," which tend to show consistent responses for renin, A II, and aldosterone to alterations in sodium intake. Catt et al. 12 and Best et al. 1 * reported a tendency for A II to rise on assumption of the upright posture or on ambulation, although the difference did not achieve statistical significance, possibly owing to the relatively small numbers of subjects in each study. It seems likely that the failure to demonstrate a correlation between circulating A II and salt intake in other studies also may be attributable in part to the small numbers of subjects studied."- 24 The values for the arterial and venous concentrations of immunoreactive A II reported here are comparable to the values in the two previous reports in which simultaneous arterial and venous measurements were made.
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- 26 The supine and erect venous values for high salt intake in this study agree well with the values of Brown et al." for five subjects on high sodium intake, but are slightly less than the values reported by Catt and associates 12 for a larger group in whom salt intake was not always specified. They are also somewhat below the values reported by Page et al. 9 and Best et al., 14 although these differences may reflect differences in salt intake and the smaller number of subjects studied in the latter reports. From all these studies it would appear that the mean value for venous A II in normal subjects on unrestricted salt intake lies between 8 and 25 pg/ml of plasma. The relationship between immunoreactive A II in arterial and venous plasma in the present study suggests that some change may occur in the metabolism of A II when there is a marked change in sodium intake. For the complete study (75 paired observations) there is a highly significant correlation between arterial and venous values (r = +0.72; P < 0.005). The regression coefficient (slope) of the relation defining venous A II as a function of arterial A II indicates that the venous value averages approximately 70% of the simultaneous arterial value. This figure agrees well with the value reported by Catt et al. ' 2 from data that included observations on both normal and disease states. When the data from the periods of high and low sodium intake were examined separately in the present study, the significantly greater slope for the sodium-restricted group appeared to be related to the frequent occurrence of venous values for A II that substantially exceeded simultaneous arterial values. Possible explanations for this difference include an increased concentration of A I in the arterial plasma delivered to peripheral capillary beds in some individuals on sodium-restricted diets, increased levels of peripheral converting enzyme activity 27 -28 in some individuals, or a combination of the two. A comparatively sensitive assay for measurement of A I in arterial and venous plasma is necessary to decide which of these two possibilities is more likely.
The question whether, in addition, there is a more avid uptake of A II in peripheral capillary beds during high sodium intake, as suggested by Brunner et al., 29 cannot be answered from the present data. Inspection of the distribution of the data in Figure 5A and 5B, however, suggests that this also may contribute to the observed differences between the high and low sodium groups. The demonstration that infusion of A II at an increasing rate leads to progressive increase in peripheral uptake (or conversion to a nonimmunoreactive metabolite) of A II during both low and high sodium intake 26 does not preclude peripheral production of A II under physiological circumstances of sodium restriction. Proof of this occurrence will require simultaneous measurement of circulating A I levels and the demonstration of a corresponding drop in the concentration of A I across peripheral capillary beds in concert with the increase in A II concentration.
The report of Catt et al. 12 , and Cain et al. 25 that a major constituent of the immunoreactivity in venous blood is the 3-8 hexapeptide of A II also raises the possibility that metabolism or degradation of A II could be quantitatively different as a function of differing salt intake. At present the quantity of blood required for the isolation and quantification of the immunoreactive degradation fragments of A II makes inclusion of such measurements in a study of this type impractical. Such cross-reactivity is not, however, an adequate explanation for the finding in our study that venous values exceed the simultaneous arterial values. The antibody used in our assay exhibited only 50% cross-reactivity with the 3-8 hexapeptide of A II. 15 Thus, if A II had only been converted to the hexapeptide in peripheral tissues with no concomitant uptake, the measured A II concentration still would have fallen below arterial levels unless significant addition of A II (i.e., conversion of A I to A II) had occurred in transit through the peripheral circulatory bed.
